Due to inclement weather, our offices will close at 12pm on Wednesday (2/19), remain closed on Thursday and Friday, and will reopen on Monday (2/24). For more information, please call our inclement weather lines at 757-264-4994 on the Peninsula and 757-264-4990 on the Southside and in Elizabeth City.
2025 UPDATES: Please bring all new insurance cards to your next appointment and verify your address and phone number when you check in at the front desk.

Clinical Research & Trials

USO 20345

A PHASE 1/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR, A SELECTIVE INHIBITOR OF NUCLEAR EXPORT, IN COMBINATION WITH RUXOLITINIB IN TREATMENT-NAIVE PATIENTS WITH MYELOFIBROSIS (XPORT-MF-034)

Disease Types: Hematology

Available at:

Norfolk (Brock Cancer Center)
Virginia Beach (Princess Anne)

Treatment Types

Services

Support During Cancer

Cancers We Treat

Blood Cancers

Blood Disorders

Find a Provider Near You

Clinical Research & Trials

Listen to our podcast

USO 20345

A PHASE 1/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR, A SELECTIVE INHIBITOR OF NUCLEAR EXPORT, IN COMBINATION WITH RUXOLITINIB IN TREATMENT-NAIVE PATIENTS WITH MYELOFIBROSIS (XPORT-MF-034)